Fasseli Coulibaly

Prof. Fasseli Coulibaly

Department of Biochemistry & Molecular Biology, Infection & Immunity program, Biomedicine Discovery Institute, Monash University, Melbourne, Australia
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2010 in Nature
Verified
Journal Article
Closed access
Ruby LawRuby Law
Ruby Law
NLNatalya Lukoyanova
Natalya Lukoyanova
IVIlia Voskoboinik
Ilia Voskoboinik
TCTom T. Caradoc-Davies
Tom T. Caradoc-Davies
KBKatherine Baran
Katherine Baran
James C WhisstockJames C Whisstock
James C Whisstock

7 December 2007 in Science
Verified
Journal Article
Closed access
PDF file
HKHae Joo Kang
Hae Joo Kang
FCFasseli Coulibaly
Fasseli Coulibaly
FCFiona Clow
Fiona Clow
Thomas ProftThomas Proft
Thomas Proft
EBEdward N. Baker
Edward N. Baker
Many bacterial pathogens have long, slender pili through which they adhere to host cells. The crystal structure of the major pilin subunit from the Gram-positive human pathogen Streptococcus pyogenes at 2.2 angstroms resolution reveals an extended structure comprising two all-β domains. The molecules associate in columns through the crystal, with each carboxyl terminus adjacent to a conserved lysine of the next molecule. This lysine forms the isopeptide bonds that link the subunits in native pili, validating the relevance of the crystal assembly. Each subunit contains two lysine-asparagine isopeptide bonds generated by an intramolecular reaction, and we find evidence for similar isopeptide bonds in other cell surface proteins of Gram-positive bacteria. The present structure explains the strength and stability of such Gram-positive pili and could facilitate vaccine development.

25 April 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
IGIrina Gutsche
Irina Gutsche
FCFasseli Coulibaly
Fasseli Coulibaly
JVJames E. Voss
James E. Voss
JSJérôme Salmon
Jérôme Salmon
JDJacques D'Alayer
Jacques D'Alayer
MFMarie Flamand
Marie Flamand
Dengue virus (DENV) causes the major arboviral disease of the tropics, characterized in its severe forms by signs of hemorrhage and plasma leakage. DENV encodes a nonstructural glycoprotein, NS1, that associates with intracellular membranes and the cell surface. NS1 is eventually secreted as a soluble hexamer from DENV-infected cells and circulates in the bloodstream of infected patients. Extracellular NS1 has been shown to modulate the complement system and to enhance DENV infection, yet its structure and function remain essentially unknown. By combining cryoelectron microscopy analysis with a characterization of NS1 amphipathic properties, we show that the secreted NS1 hexamer forms a lipoprotein particle with an open-barrel protein shell and a prominent central channel rich in lipids. Biochemical and NMR analyses of the NS1 lipid cargo reveal the presence of triglycerides, bound at an equimolar ratio to the NS1 protomer, as well as cholesteryl esters and phospholipids, a composition evocative of the plasma lipoproteins involved in vascular homeostasis. This study suggests that DENV NS1, by mimicking or hijacking lipid metabolic pathways, contributes to endothelium dysfunction, a key feature of severe dengue disease.

1 March 2005 in Cell
Verified
Journal Article
Closed access
FCFasseli Coulibaly
Fasseli Coulibaly
CCChristophe CHEVALIER
Christophe CHEVALIER
IGIrina Gutsche
Irina Gutsche
JPJoan Pous
Joan Pous
JNJorge Navaza
Jorge Navaza
FRFelix Rey
Felix Rey

8 June 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
AAAlberto A. Amarilla
Alberto A. Amarilla
JSJulian D. J. Sng
Julian D. J. Sng
Rhys ParryRhys Parry
Rhys Parry
JDJoshua M. Deerain
Joshua M. Deerain
JPJames R. Potter
James R. Potter
AKAlexander Khromykh
Alexander Khromykh
The current COVID-19 pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We demonstrate that despite the large size of the viral RNA genome (~30 kb), infectious full-length cDNA is readily assembled in vitro by a circular polymerase extension reaction (CPER) methodology without the need for technically demanding intermediate steps. Overlapping cDNA fragments are generated from viral RNA and assembled together with a linker fragment containing CMV promoter into a circular full-length viral cDNA in a single reaction. Transfection of the circular cDNA into mammalian cells results in the recovery of infectious SARS-CoV-2 virus that exhibits properties comparable to the parental virus in vitro and in vivo. CPER is also used to generate insect-specific Casuarina virus with ~20 kb genome and the human pathogens Ross River virus (Alphavirus) and Norovirus (Calicivirus), with the latter from a clinical sample. Additionally, reporter and mutant viruses are generated and employed to study virus replication and virus-receptor interactions.

1 March 2007 in Nature
Verified
Journal Article
Closed access
FCFasseli Coulibaly
Fasseli Coulibaly
ECElaine Chiu
Elaine Chiu
KIKeiko Ikeda
Keiko Ikeda
SGSascha Gutmann
Sascha Gutmann
PHPeter W. Haebel
Peter W. Haebel
PMPeter Metcalf
Peter Metcalf